Axonics (Germany) Performance
| 0I3 Stock | EUR 63.50 0.00 0.00% |
Axonics has a performance score of 6 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.0828, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Axonics are expected to decrease at a much lower rate. During the bear market, Axonics is likely to outperform the market. Axonics right now shows a risk of 2.18%. Please confirm Axonics downside deviation, information ratio, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if Axonics will be following its price patterns.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Axonics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Axonics may actually be approaching a critical reversion point that can send shares even higher in December 2024. ...more
| Begin Period Cash Flow | 241.2 M | |
| Total Cashflows From Investing Activities | -143 M | |
| Free Cash Flow | -49.6 M |
Axonics |
Axonics Relative Risk vs. Return Landscape
If you would invest 5,750 in Axonics on August 27, 2024 and sell it today you would earn a total of 600.00 from holding Axonics or generate 10.43% return on investment over 90 days. Axonics is currently producing 0.1889% returns and takes up 2.1765% volatility of returns over 90 trading days. Put another way, 19% of traded stocks are less volatile than Axonics, and 97% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Axonics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Axonics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Axonics, and traders can use it to determine the average amount a Axonics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0868
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 0I3 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.18 actual daily | 19 81% of assets are more volatile |
Expected Return
| 0.19 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 6 94% of assets perform better |
Based on monthly moving average Axonics is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Axonics by adding it to a well-diversified portfolio.
Axonics Fundamentals Growth
Axonics Stock prices reflect investors' perceptions of the future prospects and financial health of Axonics, and Axonics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Axonics Stock performance.
| Return On Equity | -0.15 | |||
| Return On Asset | -0.0624 | |||
| Profit Margin | (0.31) % | |||
| Operating Margin | (0.25) % | |||
| Current Valuation | 2.7 B | |||
| Shares Outstanding | 49.53 M | |||
| Price To Book | 5.99 X | |||
| Price To Sales | 11.31 X | |||
| Revenue | 180.29 M | |||
| EBITDA | (64.62 M) | |||
| Cash And Equivalents | 231.14 M | |||
| Cash Per Share | 5.01 X | |||
| Total Debt | 10.01 M | |||
| Debt To Equity | 0.02 % | |||
| Book Value Per Share | 11.11 X | |||
| Cash Flow From Operations | (47.31 M) | |||
| Earnings Per Share | (1.57) X | |||
| Total Asset | 547.95 M | |||
About Axonics Performance
By analyzing Axonics' fundamental ratios, stakeholders can gain valuable insights into Axonics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Axonics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Axonics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation systems. Axonics, Inc. was incorporated in 2012 and is headquartered in Irvine, California. AXONICS INC operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 416 people.Things to note about Axonics performance evaluation
Checking the ongoing alerts about Axonics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Axonics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the revenue of 180.29 M. Net Loss for the year was (80.07 M) with profit before overhead, payroll, taxes, and interest of 115.72 M. | |
| Axonics has accumulated about 231.14 M in cash with (47.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.01. | |
| Over 99.0% of the company shares are owned by institutions such as pension funds |
- Analyzing Axonics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Axonics' stock is overvalued or undervalued compared to its peers.
- Examining Axonics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Axonics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Axonics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Axonics' stock. These opinions can provide insight into Axonics' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Axonics Stock analysis
When running Axonics' price analysis, check to measure Axonics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axonics is operating at the current time. Most of Axonics' value examination focuses on studying past and present price action to predict the probability of Axonics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Axonics' price. Additionally, you may evaluate how the addition of Axonics to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stocks Directory Find actively traded stocks across global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |